NCT02278198View on ClinicalTrials.gov

Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 20, 2019

Study Completion Date

September 20, 2019

Conditions
Differentiated Thyroid Cancer
Interventions
DRUG

rhTSH

Intramuscular injections of rhTSH (Thyrogen) will be given on days 1 and 2.

Trial Locations (1)

80211

Fawn N White, Denver

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02278198 - Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123 | Biotech Hunter | Biotech Hunter